These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


194 related items for PubMed ID: 15146442

  • 21. Identification of rare anti-phospholipid/protein co-factor autoantibodies in patients with systemic lupus erythematosus.
    Szodoray P, Tarr T, Tumpek J, Kappelmayer J, Lakos G, Poor G, Szegedi G, Kiss E.
    Autoimmunity; 2009 Sep; 42(6):497-506. PubMed ID: 19626489
    [Abstract] [Full Text] [Related]

  • 22. Antibodies to beta2-glycoprotein-I: relation of anticardiolipin antibodies with clinical and laboratory parameters in patients with systemic lupus erythematosus.
    Sahin M, Duzgun N, Tunc SE, Tutkak H.
    Clin Biochem; 2007 May; 40(8):526-30. PubMed ID: 17359958
    [Abstract] [Full Text] [Related]

  • 23. Significance of antiphospholipid antibodies in lupus nephritis.
    Natejumnong C, Ruangkanchanasetr P, Aimpun P, Supaporn T.
    J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S121-8. PubMed ID: 17044463
    [Abstract] [Full Text] [Related]

  • 24. Thrombosis in systemic lupus erythematosus: congenital and acquired risk factors.
    Afeltra A, Vadacca M, Conti L, Galluzzo S, Mitterhofer AP, Ferri GM, Del Porto F, Caccavo D, Gandolfo GM, Amoroso A.
    Arthritis Rheum; 2005 Jun 15; 53(3):452-9. PubMed ID: 15934123
    [Abstract] [Full Text] [Related]

  • 25. [Incidence of selected antiphospholipid antibodies in a group of patients with systemic lupus erythematosus].
    Fojtík Z, Beránek M, Klabusay M, Korístek Z, Buliková A.
    Vnitr Lek; 2004 Apr 15; 50(4):267-73. PubMed ID: 15214295
    [Abstract] [Full Text] [Related]

  • 26. [Thrombotic phenomena and lupus anticoagulant in a series of 112 patients with systemic lupus erythematosus].
    Ordi Ros J, Vilardell Tarrés M, Barquinero Máñez J, Selva O'Callaghan A, Alijotas Reig J, Bosch Gil J.
    Rev Clin Esp; 1987 Feb 15; 180(2):66-70. PubMed ID: 3105004
    [No Abstract] [Full Text] [Related]

  • 27. Is antibody clustering predictive of clinical subsets and damage in systemic lupus erythematosus?
    To CH, Petri M.
    Arthritis Rheum; 2005 Dec 15; 52(12):4003-10. PubMed ID: 16320348
    [Abstract] [Full Text] [Related]

  • 28. [Relation of antiphospholipid antibodies to thrombotic phenomena and clinical activity of systemic lupus erythematosus].
    Font J, Cervera R, Casals FJ, Bové A, Guerrero A, López-Soto A, Ingelmo M, Urbano-Márquez A.
    Med Clin (Barc); 1988 Mar 26; 90(12):490-3. PubMed ID: 3134583
    [No Abstract] [Full Text] [Related]

  • 29. Antiphospholipid antibodies in patients with childhood onset systemic lupus erythematosus and their relatives. A French cooperative study.
    Levy M, Molta C, Meyer O, Dosquet C, Danon F, Babron MC, Montes de Oca M.
    Contrib Nephrol; 1992 Mar 26; 99():26-34. PubMed ID: 1458923
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Alterations of cerebral blood flow and antiphospholipid antibodies in patients with systemic lupus erythematosus.
    Postiglione A, De Chiara S, Soricelli A, Oriente A, Ruocco A, Spadaro G, Montefusco S, Marone G, Genovese A.
    Int J Clin Lab Res; 1998 Mar 26; 28(1):34-8. PubMed ID: 9594361
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Soluble CD154 is not associated with atherosclerosis in systemic lupus erythematosus.
    Kiani A, Mahoney JA, Petri M.
    J Rheumatol; 2007 May 26; 34(5):969-72. PubMed ID: 17407217
    [Abstract] [Full Text] [Related]

  • 35. Anticardiolipin antibodies in serum and cerebrospinal fluid from patients with systemic lupus erythematosus.
    Martínez-Cordero E, Rivera García BE, Aguilar León DE.
    J Investig Allergol Clin Immunol; 1997 May 26; 7(6):596-601. PubMed ID: 9491201
    [Abstract] [Full Text] [Related]

  • 36. [Lipoprotein(a) in systemic lupus erythematosus].
    Popkova TV, Pokrovskiĭ SN, Alekberova ZS, Reshetniak TM, Fomicheva OA, Aleksandrova EN, Kliukvina NG, Nasonov EL.
    Klin Med (Mosk); 1998 May 26; 76(1):21-4. PubMed ID: 9532909
    [No Abstract] [Full Text] [Related]

  • 37. Antiphosphatidylethanolamine antibodies are associated with an increased odds ratio for thrombosis. A multicenter study with the participation of the European Forum on antiphospholipid antibodies.
    Sanmarco M, Gayet S, Alessi MC, Audrain M, de Maistre E, Gris JC, de Groot PG, Hachulla E, Harlé JR, Sié P, Boffa MC.
    Thromb Haemost; 2007 Jun 26; 97(6):949-54. PubMed ID: 17549297
    [Abstract] [Full Text] [Related]

  • 38. Clinical utility of laboratory tests used to identify antiphospholipid antibodies and to diagnose the antiphospholipid syndrome.
    Galli M.
    Semin Thromb Hemost; 2008 Jun 26; 34(4):329-34. PubMed ID: 18814065
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Lupus anticoagulant activity and anticardiolipin antibody titre in patients with systemic lupus erythematosus.
    Isenberg DA, Colaco CB.
    Ann Rheum Dis; 1992 Aug 26; 51(8):1021-2. PubMed ID: 1417111
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 10.